Goldman Sachs has reduced Colgate-Palmolive India's price target to Rs 2,375.00 from Rs 2,630.00 following a disappointing Q4 performance. The company reported a 1.80% year-on-year revenue decline, affected by weak urban consumption and increased competition in oral care. Goldman Sachs maintains a 'sell' rating. Colgate-Palmolive expects challenges to persist through 1HFY26 but anticipates a rebound in 2HFY26. The company is focusing on premiumization strategies to navigate the current market conditions.
22May 25
Colgate-Palmolive Expects EBITDA Margins to Stay in Low 30s Range
During a recent conference call, Colgate-Palmolive, a leading consumer goods company, shared financial projections. The company anticipates its EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) margins to stay in the low 30s percentage range. This projection provides insight into the company's expected operational efficiency and profitability. No specific timeframe was provided for this outlook.
22May 25
Colgate-Palmolive Reports Sluggish Demand in Lower-Tier Urban Markets
Colgate-Palmolive has observed a persistent slowdown in consumer demand across the bottom 70% of urban markets in India, with no immediate signs of improvement. This trend, revealed during a recent conference call, highlights ongoing challenges in the FMCG sector, particularly in price-sensitive urban segments. The company's statement suggests a clear divide in consumer behavior across different urban segments and indicates potential need for strategy shifts in the FMCG industry to address prolonged market sluggishness.
21May 25
Colgate-Palmolive India: Q4 Profit and Revenue Miss Estimates, Declares Dividend
Colgate-Palmolive India's Q4 net profit declined 6.5% to ₹355.00 crore, with revenue falling 1.9% to ₹1,462.50 crore. Despite this, the company announced a second interim dividend of ₹27.00 per share, bringing the total dividend for the fiscal year to ₹51.00 per share. Full-year net sales grew 6.3% to ₹5,999.00 crore.
05May 25
Colgate-Palmolive India to Review Q4 Results on May 21
Colgate-Palmolive India's Board will meet on May 21, 2025, to approve Q4 and FY 2024-25 financial results and consider dividend declaration. Trading window closure implemented from March 31, 2025, until 48 hours post-results announcement. Investors await insights on revenue growth, profit margins, and market position in the oral care sector.